Accès ouvert
2026
article
OpenAlex
Atsushi Kunimitsu, Hirotaka Ishida, Hironobu Sasano, Hiroyuki Oshikiri et autres
Esophageal squamous cell carcinoma (ESCC) is highly aggressive malignancy.Neoadjuvant chemotherapy (NAC) followed by surgery is the standard therapeutic strategy for patients with cStage II/III ESCC; however, chemoresistance remains challenging.The nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway has been implicated …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yohei Ozawa, Hiroshi Okamoto, Yusuke Taniyama, Chiaki Sato et autres
BACKGROUND: Patients with esophageal cancer (EC) usually have multiple comorbidities, particularly, high cachexia incidence, which may lead to increased postoperative complications. A novel inflammatory marker, growth differentiation factor 15 (GDF15), was recently reported to be associated with cancer cachexia. This study evaluated …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Takeru Mozumi, Narumi Harada‐Shoji, Yohei Ozawa, Yuto Yamazaki et autres
ABSTRACT Background Esophageal squamous cell carcinoma (ESCC) represents an aggressive cancer type associated with poor prognosis, often treated with neoadjuvant chemotherapy (NAC) using cisplatin‐based regimens. However, cisplatin resistance limits therapeutic efficacy, necessitating a deeper understanding of resistance mechanisms. L‐type amino acid transporter …
jp
(code pays fourni par la source)
2025
article
OpenAlex
Kaiyuan Jiang, Hirotaka Ishida, Yusuke Taniyama, Chiaki Sato et autres
Abstract Background Our previous study confirmed that p16 is considered a reliable surrogate marker for Human papillomavirus (HPV) infection in esophageal squamous cell carcinoma (ESCC). Since neoadjuvant chemotherapy (NAC) followed by esophagectomy is the standard treatment, p16 expression may be affected by …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Chyo Kobayashi, Fumiyoshi Fujishima, Hirotaka Ishida, I Sasaki et autres
Abstract Background Observation of microvascular structures using magnifying endoscopy is useful for distinguishing between tumor and non-tumor areas, as well as for diagnosing wall invasion depth in esophageal cancer. However, while magnifying endoscopy findings are often compared with histological vascular structures, the …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Chiaki Sato, I Sasaki, Jun Takahashi, Atsushi Kunimitsu et autres
Abstract Background Esophageal achalasia is a motility disorder characterized by impaired relaxation of the lower esophageal sphincter and loss of esophageal peristalsis. While the peak age of diagnosis is reported to be in the 40s to 50s, it can also occur during …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yusuke Gokon, Yohei Ozawa, Hirofumi Ichikawa, Yusuke Taniyama et autres
Abstract Background Human epidermal growth factor receptor 2 (HER2) is a key oncogene implicated in several cancers, including breast cancer, gastric cancer, and adenocarcinoma of the esophagogastric junction (AEG). While HER2-positive tumors benefit from established therapies like trastuzumab, the clinical significance of …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Chiaki Sato, Takashi Kamei
2025
article
OpenAlex
Yuto Shimamura, Hiroki Sato, Ryusuke Yagi, Hirofumi Abe et autres
BACKGROUND AND AIMS: Pediatric achalasia and peroral endoscopic myotomy (POEM) are not well investigated. This study aimed to examine the clinical characteristics of pediatric achalasia and evaluate the long-term outcomes of POEM. METHODS: We conducted a multicenter study across 14 high-volume centers, …
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Seji Asamitsu, Yohei Ozawa, Hiroshi Okamoto, Seiryo Ogata et autres
Early detection of esophageal cancer is essential for esophagogastroduodenoscopy and histopathological diagnosis. However, endoscopic examinations are sometimes invasive, which limits their clinical application and compliance, and traditional blood tumor markers are unsuitable for cancer screening. The current study aimed to evaluate the …
jp
(code pays fourni par la source)
2025
article
OpenAlex
Takuma Miura, Eichi Takaya, Yusuke Taniyama, Chiaki Sato et autres
jp
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Iku Sasaki‐Higashimoto, Fumiyoshi Fujishima, Hirotaka Ishida, Yusuke Taniyama et autres
Fusobacterium nucleatum is implicated in esophageal cancer; however, its distribution in esophageal cancer tissues remains unknown. This study aimed to clarify the presence and distribution of F. nucleatum in esophageal cancer tissues using fluorescence in situ hybridization (FISH). Tissues collected from 70 …
jp
(code pays fourni par la source)